medical device investing AngioDynamics Announces First Patient Enrolled in NanoKnife® DIRECT Clinical Study
pharmaceutical investing ChemoCentryx Announces Positive Overall Survival Results with CCR2 Inhibitor CCX872
VVC Exploration Corporation Announces Application For Management Cease Trade Order And Provides Financing Update